Symdeko

Study to explore the use of off-label CFTR modulators that may affect CFTR function in patients with CFTR mutations that are not currently approved for these drugs

September 30, 2019

https://clinicaltrials.gov/ct2/show/NCT03587961?recrs=abdf&type=Intr&cond=Cystic+Fibrosis&lupd_s=09%2F16%2F2019&lupd_d=14

Condition : Cystic Fibrosis

Intervention : Drug: Symdeko

Sponsor : University of Alabama at Birmingham

Recruiting

Personalized Theratyping Trial

NCT03587961

Mon, 16 Jul 2018 12:00:00 EDT

Last Update Posted: 09/30/19 07:44AM

January 21, 2019

https://clinicaltrials.gov/ct2/show/NCT03587961